Legend Biotech Market Sentiment

Legend Biotech Corp

LEGNNASDAQ

Trade with Public

$19.88

-0.62-3.02%

가까이에: Aug 28, 5:00 PM EST

$19.89

0.010.05%

시간외: Aug 28, 4:00 PM EST

개요 뉴스 실적 전망 이벤트 목표가 재무심리지분 현황 비교 옵션 주식 보고서

Legend Biotech Market Sentiment

Market sentiment signals for Legend Biotech (LEGN): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus— Overweight

Short Interest▲ 21.7% short float

Options Flow▼ 4.10 P/C ratio

Insider Activity— N/A

Analyst Consensus

Overweight

21 analysts

Options Flow (P/C)

4.10

More puts — Bearish

131 calls · 537 puts

Avg Consensus PT

$65

+224.8%

Highest Price Target

$90

+352.5%

BMO Capital

Lowest Price Target

$24

+20.7%

TD Cowen

Short Interest

21.7%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Aug 12, 2026	Morgan Stanley	Matthew Harrison—	+146.4%	$48 → $49	Maintained	Overweight
Aug 12, 2026	TD Cowen	Yaron Werber—	+20.7%	$29 → $24	Maintained	Hold
Aug 12, 2026	Oppenheimer	Trevor Allred—	+101.1%	$75 → $40	Downgrade	Outperform→Perform
Aug 12, 2026	RBC Capital	Leonid Timashev—	+191.6%	$59 → $58	Maintained	Outperform
Aug 12, 2026	Barclays	Etzer Darout—	+292.2%	$80 → $78	Maintained	Overweight
Jul 28, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+226.8%	$65 → $65	Maintained	Buy
Jul 27, 2026	RBC Capital	Leonid Timashev—	+196.6%	$63 → $59	Maintained	Outperform
Jul 24, 2026	UBS	Ashwani Verma—	+40.8%	$49 → $28	Downgrade	Buy→Neutral
Jul 13, 2026	JP Morgan	Jessica Fye—	+76.0%	$35	Reinstates	Neutral
Jul 7, 2026	RBC Capital	Leonid Timashev—	+216.7%	$64 → $63	Maintained	Outperform
Jun 3, 2026	UBS	Ashwani Verma—	+146.4%	$31 → $49	Maintained	Buy
Jun 3, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+226.8%	$50 → $65	Maintained	Buy
May 18, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+151.4%	$50 → $50	Maintained	Buy
May 13, 2026	TD Cowen	Yaron Werber—	+45.8%	$21 → $29	Maintained	Hold
May 13, 2026	Morgan Stanley	Matthew Harrison—	+141.3%	$49 → $48	Maintained	Overweight
May 13, 2026	RBC Capital	Leonid Timashev—	+221.8%	$62 → $64	Maintained	Outperform
Apr 21, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+151.4%	$50 → $50	Maintained	Buy
Apr 15, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+151.4%	$50 → $50	Maintained	Buy
Mar 11, 2026	Morgan Stanley	Matthew Harrison—	+146.4%	$50 → $49	Maintained	Overweight
Mar 11, 2026	RBC Capital	Leonid Timashev—	+211.7%	$66 → $62	Maintained	Outperform
Feb 4, 2026	Barclays	Gena Wang—	+302.2%	$90 → $80	Maintained	Overweight
Jan 22, 2026	HC Wainwright & Co.	Mitchell S. Kapoor—	+151.4%	$60 → $50	Maintained	Buy
Jan 22, 2026	TD Cowen	Yaron Werber—	+5.6%	$62 → $21	Downgrade	Buy→Hold
Jan 20, 2026	RBC Capital	Leonid Timashev—	+231.8%	$66 → $66	Maintained	Outperform
Jan 7, 2026	Oppenheimer	Trevor Allred—	+277.1%	$75	Initiate	Outperform